It might be of some interest to have a closer look at 2 of Gill Jennings & Every's pharmaceutical industry clients imo...
The world's largest FMCG company, P&G and the world's 15th largest Pharmaceutical company, Teva Group and subsidiary Pliva Pharmaceuticals.
Procter & Gamble (P&G)
Companies like P&G are a force in the world. Our market capitalization is greater than the GDP of many countries, and we serve consumers in more than 180 countries. With this stature comes both responsibility and opportunity. Our responsibility is to be an ethical corporate citizen-but our opportunity is something far greater, and is embodied in our Purpose.
The simple, inspiring way to think about this opportunity is that P&G brands serve about 4.4 billion of the nearly seven billion people on the planet today. Before P&G can serve the world's remaining consumers profitably, we can reach them altruistically. We can improve their lives in ways that enable them to thrive, to increase their quality of living and, over time, to join the population of consumers we serve with P&G brands. Through our overall Live, Learn & Thrive - cause program, initiatives such as Children's Safe Drinking Water and Pampers 1 Pack = 1 Vaccine are examples of how we are improving the lives of millions of people every day.
P&G Latest News
Procter & Gamble and Powermat Join Forces to Advance and Globalize Wireless Charging
Leaders of wireless power and consumer products align to propel fast growing consumer category globally
BETHEL, Conn. & NEW YORK, Sep 14, 2011 (BUSINESS WIRE)- The Procter & Gamble Company and Powermat Ltd., the pioneer and leader in wireless charging, today announced that they intend to form a joint venture (JV) to bring the most innovative and compelling wireless power products to consumers around the world. As part of the strategic alliance between P&G's Duracell brand and Powermat, P&G also expects to make an equity investment in Powermat.
The last decade has seen a sharp growth of smart portable devices, which have become a critical part of our lives. Unfortunately, these same devices have become ever more power hungry, creating the need for a wireless charging technology that keeps those devices 'always ready'.
Several decades ago, Duracell was a pioneer in a new revolutionary product category, alkaline roundcell batteries," said Stassi Anastassov, Duracell President. "Today it is a multi-billion dollar category. In a not too distant future, we expect wireless power solutions to eliminate the hassle of multiple cords and chargers, creating a major growth opportunity. Innovation to create new solutions that touch and improve people's lives is what P&G-Duracell are all about. The JV between Duracell and Powermat puts us in the driver-seat for this >b>disruptive category creation
P&G Brands
Beauty & Grooming
3D White Always Anna Sui Aussie Braun Camay Christina Aguilera Perfumes Clairol Professional CoverGirl Crest Crest Complete Crest Pro Health DDF Dental Professionals Dolce & Gabbana Dunhill Fragrances Escada Fragrances Fekkai Fixodent Fusion Ghost Gillette Gucci Fragrances HUGO BOSS Fragrances Head & Shoulders Herbal Essences Ivory Lacoste Fragrances MACH3 Naomi Campbell Natural Instincts Nice 'n Easy Nioxin Olay Old Spice Oral-B Pantene Pert Prestobarba/Blue Puma Rejoice Rouge SK-II Safeguard Scope Sebastian Professional Secret Tampax Venus Vidal Sassoon Wella
Household Care
Ace Align Ariel Bold Bounce Bounty Cascade Charmin Cheer Comet Dash Dawn Downy Dreft Laundry Duracell Era Eukanuba Febreze Gain Iams Joy Luvs Metamucil Mr. Clean Pampers Pepto-Bismol Prilosec OTC Pringles Puffs PUR Swiffer Tide Vicks
I still can't help but think P&G's Oral Care division have incorporated what's known as "6-bromoindirubin-3 -oxime into their new Crest 3-D product range. If this is indeed true then I would have to strongly suspect they have also been collaborating with their own competition being GSK?
News Release Oral Care Leader Introduces New Complete Product Portfolio from Trusted Brands Crest & Oral-B How Do You Know It's Working? You Can Feel It!
15 September 2011 - "As part of the Crest & Oral-B Complete collection, new Crest Complete Multi-Benefit Whitening + Deep Clean toothpaste provides the protection you need with an up to two times cleaner feeling and a signal that tells you your whole mouth is clean? __________
PLIVA
"With 90 years of successful pharmaceutical experience, PLIVA is today a member of the Teva Group, one of the largest pharmaceutical companies in the world. We at PLIVA are dedicated to providing our customers with high quality, affordable medicines for a better quality of life."
Research and Development The merits for all of PLIVA's achievements to date and its current status may be greatly attributed to the in-house research and development activities which have a 70-year long tradition.
Clearly defined research and project management processes, focus on niche areas, use of state-of-the art technologies and scientific methods, and systematic protection of intellectual property rights are the basic components of PLIVA's research and development strategy.
Currently, PLIVA's R&D strategy focuses on the development of generic medicines, and Zagreb is one of the most important research centres within the Teva Group. The purpose of these development projects is the efficient development of new chemical synthesis processes for generic substances, development of new finished dosage forms, i.e. generic products, over-the-counter products or new entities (i.e. molecules under patent protection) through innovative technologies, development of analytics and organization and performance of clinical studies. _____
Miran Denac Senior Director of Global Pharma Operations
Miran Denac, Ph.D. completed postdoctoral studies at the Department of Chemical Engineering at the University of Queensland in Australia.
He joined PLIVA in 2002 in the position of senior director of Global Pharma Operations, and has held the positions of member of the Management Board of PLIVA HRVATSKA and executive director of Product Supply Croatia since 2007. He is responsible for product supply, including complete technical operations, purchasing, production, maintenance, safety at work and environmental protection, validation, facility management and warehousing. Before he joined PLIVA, Mr. Denac gained rich international experience in several renowned companies and university institutions.PLIVA __________
TEVA
Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 42,000 employees worldwide. Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence.
Teva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).
For over a century, Teva has maintained a distinct competitive edge through: * High quality offerings * Focus on customers and patients * Balanced product portfolio (both generic and innovative) * Integration of pharmaceutical and API activities * Combination of global operations with local customer responsiveness * Established international presence through a tailored network of worldwide subsidiaries.
Recent Acquisitions and Collaborations
Procter & Gamble (Joint Venture) - March 2011: The partnership between Teva and Procter & Gamble bringing together both companies' existing over-the-counter (OTC) medicines and complementary capabilities to accelerate growth. This new business model combines P&G's strong brand-building, consumer-led innovation and go-to-market capabilities with Teva's broad geographic reach, its experience in R&D, regulatory and manufacturing and its extensive portfolio of products
Teva Innovative Ventures (TIV) Teva Innovative Ventures (TIV) nurtures pharmaceutical progress by operating a global sourcing program that invests in companies with promising products and technologies at the drug discovery phase.
We seek products that:
* Answer high unmet clinical needs * Constitute new chemical/biological entities * Show proof of efficacy in relevant animal models * Have potential advantages over existing therapeutics * Own exclusive intellectual property rights
Our Acceptance Process Teva runs a 4 stage acceptance process:
* Initial screening of non-confidential information * Full product package review * Validation testing and business negotiations * Full pre-clinical/clinical development and standard FDA and EMA regulatory testing _____
OBJ Price at posting:
1.9¢ Sentiment: LT Buy Disclosure: Held
(20min delay)